Posters

Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract

Discovering immunomodulatory microbiome-derived peptides with therapeutic potential through multi-technology meta-analysis and functional assays

Targeting the CXCR3 pathway with a novel peptide drug candidate mobilizes the immune system to enhance anti-tumor immunity

A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed cell death protein-1 (PD-1) therapy by modulating chemokine receptor signaling

Strain-level meta-analysis of Parkinson’s disease-associated gut microbiome

Predicted metabolites from multiple microbiome sequencing datasets modulate Autism Spectrum phenotype in mice

Investigation of Stool-associated Microbiome of Children with Autism Spectrum Disorder and their Neurotypical Siblings Using Multi-Omics Contrast Analysis

Precision medicine approach identifies unique microbial strains associated with the IL-23/IL-17 axis in IBD

Multi-Technology Meta-Analysis (MTMA) for identification of autism-associated fecal metabolites as potential drug candidates

Incidence and diversity of insecticidal proteins in metagenomes from targeted environments